 |
| Kimia Farma / kimiafarma.co.id |
PT Kimia Farma (Persero) Tbk - Kimia Farma is a reputable state-owned pharmaceutical company in Indonesia. The Company is based in Jakarta and provides integrated health services, namely manufacturing, laboratories, distribution, marketing, retail pharmacies, and health clinics. As of December 2011, the Company supported by 5 plants, 43 wholesalers (KFTD), 395 units of phamacies, 37 units of clinic labs, and 10 health clinics. The Company had 2 direct subsidiaries, namely PT Kimia Farma Trading & Distribution, and PT Kimia Farma Apotek. Based on PT Kimia Farma (Persero) Tbk Annual Report 2011, the net sales in 2011 reached Rp3.48 trillion (increased by 9.34%) with net profit rose by 23.83% to Rp171.76 billion compared to 2010. Kimia Farma's total asset also increased by 8.26% to Rp1.79 trillion.
In line with its vision, to become an integrated corporation in health sectors which is able to generate sustainable value growth through the configuration and coordination of synergistic businesses, currently PT Kimia Farma (Persero) Tbk invites the best candidates to join as following positions below which will based in Distribution Branch Office Denpasar Bali
Frontliner
Requirements
Requirements
- Male / Female
- Min. SMF/D3 majoring Pharmacy
- Preferably experienced min 1 year
- Preferably active in English
- Understand the types of drugs
- Responsible and Honest
Asisstant Apoteker
Requirements
- Male / Female
- Min. SMF/D3 majoring in Pharmacy
- Preferably experienced min 1 year
- Preferably active in English
- Understand the types of drugs
- Responsible and Honest
Requirements
- Male / Female
- Min. S1 majoring in Pharmacy
- Preferably experienced min 1 year
- Preferably active in English
- Understand the types of drugs
- Responsible and Honest
For further detail information about job requirements and how to apply, please refer official source from JobsDB on following link below. All applications will be treated as strictly confidential. Only short-listed candudates will be notified.
0 comments:
Posting Komentar